Compounds > alendronate

alendronate and jaw

alendronate has been researched along with jaw in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mehrotra, B; Ruggiero, SL1
Beirne, JC; Khosa, AD; Nayyar, MS1
Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A1
Azambuja, AA; Campos, MM; Cherubini, K; Maahs, MP; Salum, FG1
Grey, A1
Cheung, A; Seeman, E1
Andrade, CR; Conte Neto, N; Guimarães, M; Marcantonio, E; S Bastos, A; Spolidorio, LC1
Costela-Ruiz, VJ; García-Martínez, O; Illescas-Montes, R; Manzano-Moreno, FJ; Melguizo-Rodriguez, L; Ramos-Torrecillas, J; Ruiz, C1

Reviews

1 review(s) available for alendronate and jaw

ArticleYear
Osteochemonecrosis of jaws and bisphosphonates.
    Irish medical journal, 2007, Volume: 100, Issue:3

    Topics: Alendronate; Bone Density Conservation Agents; Etidronic Acid; Humans; Jaw; Osteonecrosis; Osteoporosis; Risedronic Acid; Risk Factors

2007

Other Studies

7 other study(ies) available for alendronate and jaw

ArticleYear
Ten years of alendronate treatment for osteoporosis in postmenopausal women.
    The New England journal of medicine, 2004, Jul-08, Volume: 351, Issue:2

    Topics: Alendronate; Bone Regeneration; Female; Humans; Jaw; Osteonecrosis; Osteoporosis, Postmenopausal; Risk Factors

2004
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
    Clinical oral investigations, 2010, Volume: 14, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Jaw; Jaw Diseases; Male; Mandibular Diseases; Maxillary Diseases; Microscopy, Electron, Scanning; Middle Aged; Osteomyelitis; Osteonecrosis; Osteoporosis; Osteoradionecrosis; Pamidronate; Time Factors; Zoledronic Acid

2010
Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.
    Head & neck, 2011, Volume: 33, Issue:2

    Topics: Alendronate; Animals; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Drug Therapy, Combination; Imidazoles; Jaw; Osteonecrosis; Random Allocation; Rats; Rats, Wistar; Tooth Extraction; Zoledronic Acid

2011
Teriparatide for bone loss in the jaw.
    The New England journal of medicine, 2010, Dec-16, Volume: 363, Issue:25

    Topics: Alendronate; Bone Density Conservation Agents; Bone Regeneration; Combined Modality Therapy; Humans; Jaw; Jaw Diseases; Osteonecrosis; Periodontitis; Teriparatide

2010
Teriparatide therapy for alendronate-associated osteonecrosis of the jaw.
    The New England journal of medicine, 2010, Dec-16, Volume: 363, Issue:25

    Topics: Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Bone Regeneration; Female; Humans; Jaw; Jaw Diseases; Osteonecrosis; Radiography; Teriparatide

2010
Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents.
    International journal of experimental pathology, 2013, Volume: 94, Issue:1

    Topics: Alendronate; Alkaline Phosphatase; Animals; Biomarkers; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Remodeling; Collagen Type I; Disease Models, Animal; Jaw; Male; Molar; Orthognathic Surgical Procedures; Peptides; Rats; Time Factors; Tooth Extraction; Weight Gain

2013
Impact of bisphosphonates on the proliferation and gene expression of human fibroblasts.
    International journal of medical sciences, 2019, Volume: 16, Issue:12

    Topics: Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Cell Differentiation; Cell Proliferation; Diphosphonates; Fibroblasts; Gene Expression Regulation; Humans; Ibandronic Acid; Jaw; Osteoblasts; Real-Time Polymerase Chain Reaction; Zoledronic Acid

2019